Cancer Medicines Take More than Two and a Half Years to Reach the Patient

Sapo

Lean Right

Factuality

Ownership

New medicines can transform the lives of patients, but the approval of an innovation does not mean that this immediately reaches those who need it. In Portugal, waiting times, regional inequalities and different obstacles in access continue to mark the path to treatment.

Diário de Coimbra

Factuality

Ownership

Analysis reveals a higher delay than the European average and highlights difficulties in access to innovation and essential support for cancer patients

Correio da Manhã

IOL Portugal

View article

Reposted by

IOL Portugal

Factuality

Ownership

Data reported indicate that, between 2020 and 2025, 57 cancer drug processes were submitted to Infamed.

Noticias ao Minuto

Factuality

Ownership

Oncological medicinal products take an average of more than two and a half years to reach patients in Portugal since European approval, according to data from a analysis of dozens of studies published today.